Together, IHC staining and bioinformatic analysis demonstrate that expression of Endo180 in sarcomas and CAFs is elevated compared with normal tissue fibroblasts, indicating that on-target, off-tumor toxicities would be limited in patients. The gene discussed is MRC2; the disease is sarcoma.